Adverse Event Reporting
| VAERS ID | 1847787 |
|---|---|
| Gender | Female |
| Age | |
| StateCode | FR |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | FG3739 |
| Number of vaccinations | 2 |
| Vaccinated | 2021-09-17 |
| Onset | 2021-09-17 |
| Condition | Life Threatening |
Symptoms
- Blood test
- Chest X-ray
- Lymphadenopathy
- Electrocardiogram
- Ultrasound scan
- Echocardiogram
- Pericarditis
- Maternal exposure during pregnancy
- Cardiac function test
Current Illness
Preexisting Conditions
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Test Name: blood test; Result Unstructured Data: Test Result:unknown results; Test Name: specific cardiological test; Result Unstructured Data: Test Result:unknown results; Test Name: chest X-ray; Result Unstructured Data: Test Result:unknown results; Test Name: echocardiogram; Result Unstructured Data: Test Result:unknown results; Test Name: electrocardiogram; Result Unstructured Data: Test Result:unknown results; Test Name: bilateral axillary ultrasound; Result Unstructured Data: Test Result:unknown results
Write-up
pericarditis; swollen lymph nodes; became pregnant while taking BNT162B2/12 days pregnant at the onset of the event; This is a spontaneous report from a contactable consumer (patient) downloaded from the Regulatory Agency (RA)-WEB IT-MINISAL02-803821.
A 25-years-old female patient received the second dose of BNT162B2 (COMIRNATY) intramuscular, administered in right arm (reported as right shoulder) on 17Sep2021 (Lot Number: FG3739) as dose 2, 0.
3 ml single for COVID-19 immunisation.
The patient medical history was not reported.
The patient's concomitant medications were not reported.
The patient was pregnant at the time of vaccination - impact on quality of life (10/10).
The patient previously received the first dose of COVID-19 vaccine (Manufacturer unknown) on unknown date for COVID-19 immunisation.
On 07Oct2021, the patient experienced swollen lymph nodes and pericarditis 20 days after the second dose of the BNT162B2.
The patient wished herself a speedy recovery.
Events seriousness criterial reported as life-threatening.
The patient reported she became pregnant while taking BNT162B2.
The patient was 12 days pregnant at the onset of the event.
The patient underwent lab tests and procedures which included bilateral axillary ultrasound, electrocardiogram, echocardiogram, chest X-rays, specific cardiological and general blood tests on unknown date with unknown result.
Events outcome was unknown.
No follow-up attempts possible.
No further information expected.